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Aims: Marathon running is a popular ambition in modern societies inclusive of non-
athletes. Previous studies have highlighted concerning transient myocardial dysfunction
and biomarker release immediately after the race. Whether this method of increasing
physical activity is beneficial or harmful remains a matter of debate. We examine in
detail the real-world cardiovascular remodeling response following competition in a
first marathon.
Methods: Sixty-eight novice marathon runners (36 men and 32 women) aged 30 ± 3
years were investigated 6 months before and 2 weeks after the 2016 London Marathon
race in a prospective observational study. Evaluation included electrocardiography,
cardiopulmonary exercise testing, echocardiography, and cardiovascular magnetic
resonance imaging.
Results: After 17 weeks unsupervised marathon training, runners revealed a
symmetrical, eccentric remodeling response with 3–5% increases in left and right
ventricular cavity sizes, respectively. Blood pressure (BP) fell by 4/2 mmHg (P < 0.01)
with reduction in arterial stiffness, despite only 11% demonstrating a clinically meaningful
improvement in peak oxygen consumption with an overall non-significant 0.4 ml/min/kg
increase in peak oxygen consumption (P = 0.14).
Conclusion: In the absence of supervised training, exercise-induced cardiovascular
remodeling in real-world novice marathon runners is more modest than previously
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described and occurs even without improvement in cardiorespiratory fitness. The
responses are similar in men and women, who experience a beneficial BP reduction
and no evidence of myocardial fibrosis or persistent edema, when achieving average
finishing times.
Keywords: cardiovascular remodeling, athlete’s heart, sports cardiology, endurance exercise, cardiorespiratory
fitness, marathon
INTRODUCTION
“If you want to run, run a mile. If you want to experience a
different life, run a marathon” Emil Zátopek, Olympic long-
distance runner.
Running a marathon is an increasingly popular personal
challenge for many non-athletes, often with the intention of
fundraising for good causes. Approximately 349,000 people
across Europe and 414,000 people across North America take
part in marathon races every year (Andersen, (2014–2017)). The
London Marathon is the third largest in the world (Andersen,
(2014–2017)) and currently generates over £60 million/year
in charity donations (London Marathon sets another record,
2017). London Marathon runners require no prior experience
and there is no qualifying time as a barrier to race entry,
with the majority taking part as first time marathon runners
(Cave and Miller, 2016).
In the 1970s, it was proposed that the type of person
capable of completing a marathon might acquire immunity to
atherosclerosis (Bassler, 1977, 1978). It has since been made
clear that this is not the case and in fact undertaking vigorous
physical activity is associated with a transient 5.9 relative risk of
myocardial infarction (Mittleman et al., 1993) and 16.9 relative
risk of sudden cardiac death (Albert et al., 2000). The absolute
risk of sudden cardiac arrest during a marathon is low at 1.01
per 100,000 participants (Kim et al., 2012) and can paradoxically
be reduced by greater habitual vigorous exercise (Siscovick
et al., 1984; Mittleman et al., 1993; Albert et al., 2000; Chugh
and Weiss, 2015). Over the last two decades, multiple studies
have highlighted potential cardiovascular dangers of marathon
running including transient left and right ventricular dysfunction
(Neilan et al., 2006a; La Gerche et al., 2012; Gaudreault et al.,
2013), myocardial injury with release of cardiac troponin (Neilan
et al., 2006a; Shave et al., 2010; Lara et al., 2019) and for
those engaging repeatedly, myocardial fibrosis (Möhlenkamp
et al., 2008; Breuckmann et al., 2009; Wilson et al., 2011; Tahir
et al., 2018), coronary calcification (Aengevaeren et al., 2017;
Merghani et al., 2017), and arrhythmias (Heidbuchel et al., 2003;
Mont et al., 2009).
Despite these reported dangers, each year over 400,000 people
apply to the ballot hoping to secure a London Marathon place
(McGuire, 2018). Large observational data would suggest that for
every hour invested in running, there is a return of 7 h longevity
(Lee et al., 2017). Some studies show no ceiling of benefit but
progressively diminishing returns with increasing volumes of
physical activity (Wen et al., 2011; Kyu et al., 2016; Lear et al.,
2017), while others describe a reverse J-shaped curve where
potential harm emerges at greater than 10-fold the recommended
minimum physical activity levels (Lee et al., 2014; Arem et al.,
2015; Armstrong et al., 2015; Schnohr et al., 2015).
It remains debatable whether preparation for and
participation in a 42-km (26-mile) footrace constitutes a
healthy promotion of increased regular physical activity or
a potentially cardiotoxic dose of strenuous exercise (Predel,
2014). Previous studies characterizing the remodeling changes
associated with a marathon run have been limited by small
sample size (Mousavi et al., 2009; Gaudreault et al., 2013;
Arbab-Zadeh et al., 2014), exclusion of participants who did
not adhere to structured training plans (Zilinski et al., 2015)
or included supervised preparatory training for a much longer
period than most typical runners would undertake (Arbab-
Zadeh et al., 2014). For these reasons, our current knowledge
of exercise-induced cardiovascular remodeling resulting from
marathon training is somewhat skewed. Given the popularity
of marathon running in modern societies, it is valuable for
clinicians, runners, and prospective marathon runners to gain
greater understanding of the cardiovascular changes resulting
from a single marathon in real-world novice runners, for
whom this may represent the greatest athletic feat of their lives.
Increasing the generalizability of our findings to real-world
novice marathon runners, participants were not excluded for not
returning training logs or for failing to follow training plans.
The aim of this study was to assess cardiovascular remodeling
in detail occurring in real-world, typical novice marathon
runners, inclusive of all those finishing the race, without
exclusion of those non-adherent to training programs. We sought
to recruit a sufficient proportion of men and women to explore
gender differences. In recognition that occult atherosclerotic
coronary artery disease is an important confounding factor
to outcomes of interest, we restricted our study to subjects
aged 18–35 years. This group harbors a low prevalence
of atherosclerotic disease and greater cardiorespiratory
trainability (Ogawa et al., 1992; Green and Crouse, 1993).
We hypothesized that real-world cardiovascular remodeling
in unsupervised, novice marathon runners would be more
modest than previously described work involving supervised
marathon training and that similar responses would be seen
in men and women.
MATERIALS AND METHODS
Study Design and Study Population
The study was a prospective observational study. Subjects
were considered for inclusion if they were aged 18–35 years
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old and had never run a marathon distance previously.
Individuals were excluded if they had pre-existing cardiovascular
disease during preliminary investigations or contraindication
to cardiac magnetic resonance (CMR). Novice marathon
runners within the specified age range, totaling 4,170, were
identified through the database records of the organizers (Virgin
Money London Marathon) and received notification of the
study through a targeted e-mail advertisement 2 weeks after
notification of their place in the 2016 London Marathon.
The London Marathon is run over a predominantly flat
course, through the capital city center around the river
Thames, covering 42.2 km (26 miles and 385 yards). The
race organizers received 247,069 applicants for ballot places
in 2015 with 51,000 places given, culminating in 39,140
marathon finishers in 2016. Interested runners made contact
through a call center and those fulfilling inclusion the criteria
were subsequently contacted by telephone and appointed to
a study day for recruitment. Written consent was obtained
from all participants and the National Research Ethics Service;
Queen Square, London committee granted ethical approval
(15/LO/086). The trial is registered on ClinicalTrials.gov,
number NCT02568072.
Testing took place in two parallel identical circuits
where subjects were changed into gowns (to ensure that no
ferromagnetic materials were taken into the CMR environment),
height and weight were recorded, followed by cannulation
and venipuncture prior to CMR. Subjects then underwent a
resting echocardiogram, followed by electrocardiography and
blood pressure (BP) measurement. Finally, subjects underwent
cardiopulmonary exercise testing using a semi-recumbent tilting
cycle ergometer combined with echocardiography in their
exercise clothes (Figure 1). Testing was consistent between
subjects and between visits.
Running Training
Subjects were encouraged to follow a beginner’s training plan,
consisting of approximately three runs per week, increasing
in difficulty over a 17-week period leading up to the London
Marathon race, which is the recommendation of the race
organizers (London Marathon, 2018) (Beginner 17 Week
Training Plan in Supplementary Data Sheet S1). Subjects
wishing to follow alternative, higher intensity training plans were
not discouraged from doing so.
Allometry, Bioimpedance, and Blood
Pressure
Height was recorded using a standard stadiometer. Weight and
body fat percentage were measured using digital bioimpedance
scales (BC-418, Tanita, United States). Peripheral and central
BPs were measured after 5 min of rest in accordance with
international standards (Williams et al., 2004), supra-systolic
oscillometric BP was measured in both arms over 10 s at
200 Hz in a semi-supine position using a Cardioscope II
BP+ device (USCOM, Sydney, NSW, Australia), which employs
an upper arm cuff, as previously described (Costello et al., 2015).
An ensemble averaged central pressure estimate was derived
from the brachial BP and supra-systolic arterial waveforms
to estimate central systolic and diastolic BP. At baseline, if
the right arm BP was > 10 mmHg greater than the left
arm this was used, otherwise the left arm BP was used and
repeated measurements of BP used the same arm as the
baseline measurement. All BP measurements were recorded by
the same investigator (RB) supported by one of five cardiac
research nurses working a rotational day schedule, all receiving
the same training on recording BP using the Cardioscope
II BP+ device.
Electrocardiography
Two-minute ECG recordings were acquired digitally (CardioSoft,
GE Healthcare, Milwaukee, WI, United States) according to
internationally accepted practices (Eldridge et al., 2014).
Echocardiography
Resting and exercise two-dimensional echocardiography was
performed (Vivid E9, GE Vingmed Ultrasound, Horten, Norway)
with standard cardiac views obtained and analyzed according to
contemporary European Association of Cardiovascular Imaging
guidelines (Lang et al., 2015). Mean frame rates ranged from
72 ± 11 to 78 ± 11 frames/s for long- and short-axis views,
respectively. Five cardiac cycles were stored in a cineloop format,
optimized for offline 2D speckle-tracking echocardiographic
analysis. All automatic image enhancement and harmonics
were enabled. Images were saved digitally for subsequent
offline analysis by speckle tracking analysis with dedicated
software using automated function imaging (EchoPAC Version
113, GE Vingmed Ultrasound AS, Horten, Norway). Twist
and torsion were calculated as previously described (Kinova
et al., 2018). Studies were performed by nine accredited and
experienced cardiac physiologists working a rotational day
schedule. Measurements were made by a single investigator (AD)
utilizing edge detection software (Auto-EF) for calculation of
ventricular volumes and visual confirmation with correction
where endocardial border definition was sub-optimal.
Cardiovascular Magnetic Resonance
(CMR)
Cardiac magnetic resonance scans were performed using a
1.5 T magnet (Aera, Siemens Medical Solutions). LV and RV
function, volumes, and myocardial mass (excluding papillary
muscles) were assessed by cine steady-state free precession
sequences and analyzed by a single investigator (AD) using Circle
CVI42 (Circle Cardiovascular Imaging Inc., Calgary, Canada)
semi-automated software including tissue tracking for strain
analysis. Left and right atrial EDV and ESV were derived
by manually tracing endocardial atrial contours, as previously
described (Petersen et al., 2017). Studies were performed by five
experienced radiographers and five experienced clinical research
fellows working a rotational day schedule.
Late gadolinium enhancement (LGE) images were
obtained 10 min after the intravenous bolus injection of
0.1 mmol/kg gadolinium-based contrast (gadoterate meglumine,
Dotarem, Guerbet, LLC).
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FIGURE 1 | The study visit testing circuit. BP, blood pressure; CMR, cardiac magnetic resonance; CPEX, cardiopulmonary exercise test; ECG, electrocardiogram.
Parametric Mapping for Myocardial
Tissue Characterization: T1, T2, and ECV
Mid-ventricular short axis pre and post-contrast (15 min
post 0.1 mmol/kg Dotarem) T1 maps were acquired by
Modified Look-Locker Inversion recovery (MOLLI) sequence
[pre: 5s(3s)3s, post: 4s(1s)3s(1s)2s]. MOLLI T1 maps with motion
correction were used to generate automated extracellular volume
(ECV) maps with contours in the mid-anteroseptum used for
analysis, as previously described (Rosmini et al., 2018) based on
the following equation:
ECV = [1−Hct]×
(
1
[
1/T1myo
]
1
[
1/T1blood
])
Mid-ventricular short axis T2 maps were acquired with the mean
segmental pixel value calculated from a region of interest drawn
in the mid-anteroseptum.
Aortic Pulse Wave Velocity
Pulse wave velocity was measured with phase-contrast MR
imaging. Phase-contrast sequences were acquired in the
ascending aorta (at the level of the pulmonary bifurcation) and
the descending thoracic aorta (at the level of the diaphragm) with
a prospectively triggered, velocity encoded spoiled gradient echo
sequence (flip angle = 20o; pixel bandwidth = 457 Hz/pixel;
uninterpolated resolution = 2.0 × 2.0 mm; acquisition
matrix = 192 × 192; echo time = 2.46 ms; repetition
time = 9.24 ms, slice thickness 6 mm; FOV: 380 × 380 mm,
matrix: VENC: 150 cm/s). For assessment of the aortic arch
length, an oblique-sagittal image of the aorta (candy cane view)
was obtained using ECG-gated steady state free precession
acquisition with breath hold. Calculation of flow wave transit
time, aortic distance, and aortic pulse wave velocity was then
undertaken as previously described (Bhuva et al., 2019, 2020).
Imaging Analysis
All resting imaging studies were analyzed by an accredited,
experienced cardiologist (AD), blinded to subject identity and
time point; 15 CMR studies were randomly selected and
reanalyzed independently by another experienced cardiologist
(AB or KM) for assessment of inter-observer variability. Exercise
echocardiographic studies were analyzed by an accredited cardiac
physiologist (JZ) and aortic pulse wave velocity was analyzed by
two investigators (AB and NN).
Blood Samples
Non-fasting blood samples were collected into standard
ethylenediaminetatraacetic acid (EDTA) and serum separating
(SST) blood collection tubes during intravenous cannulation
prior to CMR. On-site laboratory analysis included complete
blood count, used to calculate the ECV and a renal chemistry
sample, including creatinine and electrolytes. The remainder
of whole blood and serum samples were saved in cryovials
and stored at −80◦C in refrigerators at St George’s,
University of London.
Cardiopulmonary Exercise Testing
Cardiopulmonary exercise testing was performed using a semi-
recumbent tilting cycle ergometer (Schiller ERG 911 BP/LS,
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Schiller, Switzerland) with an incremental ramp protocol of 15–
30 W/min, based on a pre-specified algorithm incorporating
subject height and gender (Supplementary Table S1). Subjects
were exercised to volitional exhaustion with continuous ECG
monitoring. Maximal effort was assessed by the presence of
a plateau in oxygen uptake seen in Wasserman Plot panel
3, respiratory exchange ratio (RER) > 1.15 and subject
perceived exhaustion, as recognized parameters of assessment
of effort (Society, 2003). Achievement of maximal predicted
heart rate was a less reliable marker of maximal effort with
testing conducted on a semi-recumbent cycle, as compared
to a treadmill. Breath-by-breath pulmonary gas exchange and
ventilation were continuously measured by metabolic cart
(Quark CPET, COSMED, Rome, Italy), as previously described
(Sharma et al., 2000). The ventilatory threshold was determined
by the V-slope method, where two intersecting lines were drawn
using dedicated software (Omnia, COSMED, Rome, Italy) on
the VCO2 vs VO2 Wasserman Plot panel 5. Echocardiography
was performed after 5 min exercise in the semi-recumbent
position to assess augmentation in LV ejection fraction (EF)
and stroke volume. To fully characterize exercise ability and
potential using the semi-recumbent ergometer, both maximal
(maximal VO2 and percentage predicted maximal VO2) and
submaximal indices [oxygen uptake efficiency slope (OUES)]
were assessed. In order to appropriately classify cardiorespiratory
trainability by accounting for the random within-individual
variation and measurement error, a combination of the technical
error of measurement (TEM) and the minimal clinically
important difference (MCID) were incorporated, as previously
described (Williams et al., 2019). Studies were performed by
four experienced cardiac physiologists working a rotational
day schedule and analyzed by a single investigator (AD).
Target exercise times were 5–12 min, if a subject at baseline
exercised for more than 12 min to volitional exhaustion
the ramp protocol was increased by 5 W/min on post
marathon testing.
Statistical Analysis
Statistical analyses were performed with R version 3.3.0
(R Project for Statistical Computing). Project data were
curated using REDCap data tools hosted at University College
London (Harris et al., 2009). Data were tested for normality
with the Shapiro–Wilk test and assessed in histograms.
Normally distributed data are presented as mean ± standard
deviation and skewed data are presented as median with
inter-quartile range (IQR). Differences between baseline and
post marathon time points were compared using a paired
t-test, if parametric, or Wilcoxon signed rank test if non-
parametric and expressed as mean difference. Differences in
paired categorical data were compared using McNemar’s test.
Comparisons of two unpaired groups (likely responder and
likely adverse responder) were assessed using a two-sample
independent t-test. Comparisons of three unpaired groups (final
cohort, injured, lost to follow up) were assessed by one-way
ANOVA if continuous or by Chi-squared test if categorical.
Reproducibility of measurements both between and within raters
was assessed with two-way, mixed single measures intraclass
correlation coefficient (ICC) analysis for absolute agreement.
ICC > 0.75 = excellent, 0.6–0.74 = good, 0.4–0.59 = fair,
and < 0.4 = poor, according to a previously published scale
(Cicchetti, 1994). Statistical significance was defined as a two-
tailed value of P < 0.05.
RESULTS
Study Cohort Demographics and Race
Finishing Times
One hundred and twenty subjects were recruited into the study.
Twenty-eight were lost to follow up as they only attended the
baseline evaluation and did not return for follow up evaluation
post marathon, predominantly due to scheduling difficulties in
the required timeframe. Of these 28, 12 ran the London Marathon
and 16 did not. All 28 were able to confirm that they were alive at
the end of the study period and had suffered no clinical cardiac
events. In addition, 24 were unable to complete their training
due to musculoskeletal injury, they deferred their marathon
places and despite not running the marathon they returned
for repeat evaluation. These subjects reported continuing light
exercise training once their injuries improved but were no
longer adherent to a marathon running training plan. They
were not included in the primary analysis but their results
are appended separately in Supplementary Table S2. The final
cohort of marathon completers consisted of 68 novice runners
who underwent evaluations at study entry, 186 ± 4 days before
the London Marathon in October 2015 and 16 ± 4 days after
in May 2016 (Figure 2). Only the results from these marathon
completers were included in the main analysis. One marathon
completer omitted CMR on post marathon evaluation due to
early pregnancy. Baseline measures are presented in Table 1.
There was no difference in baseline characteristics between
participants completing the study and those who were lost to
follow up or injured. Subjects self-reported a median of 2.0 h
of exercise per week (range 0–10 h, IQR 1.5–2.5 h) at the
time of study entry.
The median race finishing time of the study cohort was
04:31:00 (HH:MM:SS, IQR: 04:08:30–05:02:00, range: 02:56:10–
06:51:20). Median finishing times for men and women were
04:14:30 (IQR: 03:42:20–04:42:00) and 04:43:40 (IQR: 04:29:00–
05:19:50), respectively. These are above the published median
times for the 2016 London Marathon general race, which
includes repeat marathon runners, at 04:04:23 for men and
04:39:27 for women (Mirror, 2016; Run247, 2018), though highly
comparable (Figure 3).
Training Data
Thirty-eight subjects (32%) provided detailed training and
detraining data recorded electronically on portable devices. The
training activities of this sub-group are shown in Figure 4
and Supplementary Figures S1, S2. The median training
times fell below the recommended 17-week training plan,
averaging 78% compliance when studied on a week-to-week basis
(Supplementary Table S3).
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FIGURE 2 | Flow diagram of the trial profile. LQTS, long QT syndrome.
Cardiac Structure and Function
Structural and functional CMR measures of cardiac chambers are
detailed in Table 2 and Supplementary Table S4, demonstrating
balanced eccentric remodeling and no change in LV or RV EF.
Cardiac remodeling changes were similar in both men and
women, as detailed in Table 3 and Supplementary Table S5. No
changes were observed in echocardiographic diastolic function,
myocardial strain, peak rotation, twist, or torsion parameters
(Supplementary Table S4). LV stroke volume and EF at 5 min
of exercise on cardiopulmonary exercise testing did not change
after training. Limitations in image quality prevented accurate
assessment of echocardiographic indices at peak exercise.
T1 and T2 values from multiparametric mapping did not
change. A 1% reduction in ECV was matched by a 1% rise in
blood hematocrit with no change in the myocardial partition
coefficient, post-contrast T1 myocardial, or blood values. There
was no evidence of LGE in any subject, including the additional
24 subjects who did not run the marathon due to injury but
attended for re-evaluation.
Blood Pressure and Arterial Stiffness
Reductions were seen in the aortic pulse wave velocity (ascending
to descending aorta), peripheral, and central BP. BP fell by
4/2 mmHg (P < 0.01) and aortic pulse wave velocity across
the whole aorta fell by 0.2 m/s (P = 0.02). In sub-group
analysis women, who were also noted to have lower baseline BP,
experienced a greater BP reduction than men.
Cardiopulmonary Exercise Testing
Six (9%) of subjects at baseline exercised to volitional exhaustion
in over 12 min, for whom the ramp protocol was increased by
5 W/min when returning for repeat evaluation post marathon.
The remaining 62 subjects (91%) were tested on the same
ramp protocol post marathon as the baseline exercise tests.
Mean baseline exercise time was 09:38 ± 01:32 (MM:SS), which
increased to 10:10± 01:42 post marathon (P = 0.01).
No changes were seen in maximal oxygen consumption
(VO2), as absolute values and percentage of predicted peak,
OUES, or maximum metabolic equivalents achieved (METS),
despite a mean increase in exercise time of 32 s and a median
increase in peak power achieved of 15 W (P < 0.01). The
ventilatory anaerobic threshold fell post marathon, both in
absolute value and as a percentage of maximal VO2.
Using the previously established coefficient of variation
of 5.6% (Katch et al., 1982), the TEM was calculated by
multiplying this value by the mean baseline peak VO2, which was
37.91 ml/min/kg in this cohort, therefore TEM = 2.12 ml/kg/min.
Applying previously defined criteria for MCID and peak VO2
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TABLE 1 | Baseline characteristics of study participants in the final cohort and
comparison to subjects not completing training due to injury and lost to follow up.
Final cohort
completing
marathon (n = 68)
Injured—unable
to complete
training (n = 24)
Lost to
follow up
(n = 28)
P-value
Age 29.5 ± 3.2 28.8 ± 3.3 27.9 ± 3.8 0.12
Male n(%) 36 (53) 10 (42) 14 (50) 0.64
Ethnicity (%) 0.64
White European 90 96 89
Other 10 4 11
Smoking status
(%)
Never smoker 82 83 71 0.65
Ex-smoker 12 8 21
Current smoker 6 8 7
Hours of
exercise/week
2 [1.5, 2.5] 2 [1.5, 2.6] 2 [1.5, 3.1] 0.89
Weight (kg) 71.3 ± 12.5 72.7 ± 12.6 71.6 ± 14.7 0.74
BMI (kg/m2) 23.4 ± 2.9 24.0 ± 3.1 24.4 ± 3.7 0.33
Peak VO2
(ml/kg/min)
37.1 [32.8, 42.3] 37.2 [34.0, 40.5] 35.0 [30.4,
40.8]
0.39
Percentage
predicted peak
VO2 (%)
106.7 ± 16.2 111.2 ± 14.9 102.7 ± 17.4 0.18
Systolic BP
(mmHg)
119.6 ± 11.8 118.4 ± 11.5 121.8 ± 9.0 0.53
Diastolic BP
(mmHg)
73.7 ± 5.3 74.5 ± 5.9 75.6 ± 5.7 0.29
Heart rate
(bpm)
66.3 ± 13.8 68.8 ± 14.4 68.4 ± 14.9 0.69
iLV mass (g/m2) 64.9 ± 12.1 63.4 ± 9.8 63.2 ± 11.6 0.76
iLV EDV (ml/m2) 91.0 ± 14.3 90.0 ± 12.8 90.1 ± 12.0 0.93
iRV EDV
(ml/m2)
92.6 ± 14.3 93.0 ± 15.4 93.1 ± 13.7 0.99
Data expressed as mean ± SD if normally distributed. If non-normally distributed
data expressed as median [IQR]. BMI, body mass index; BP, blood pressure; EDV,
end-diastolic volume; iLV indexed to body surface area left ventricular; iRV, indexed
to body surface area right ventricular; VO2, oxygen consumption.
response (Williams et al., 2019), resulted in 7.6% likely adverse
responders, 51.5% likely non-responders, 30.3% uncertain, and
10.6% likely responders in this population (Figure 5).
Those subjects who were likely responders based on the
change in peak VO2 (n = 7) did not demonstrate differences
in systolic function, cardiac dimensions, BP, or aortic pulse
wave velocity compared with those subjects who were likely
adverse responders (n = 5). Comparing the available mean weekly
exercise volumes over the 17-week training period between likely
responders (n = 4) with likely adverse responders (n = 3), there
were no differences (Supplementary Table S6).
Electrocardiography
No changes were seen in resting heart rate, PR interval,
QRS duration, corrected QT interval, or Sokolow–Lyon voltage
(S in V1 + R in V5 or V6, depending on the largest
values). The prevalence of voltage criteria for ventricular
hypertrophy and early repolarization pattern did not change
(Supplementary Table S4).
Allometry, Body Composition, and Renal
Function
There were no significant changes in weight, body mass index
or percentage body fat over the study period. Serum creatinine
decreased by 5 µmol/l (P < 0.01) post marathon.
Reproducibility of Measurements
Intra-observer and inter-observer agreement for
all cardiac imaging measurements were excellent
(Supplementary Tables S7, S8).
DISCUSSION
The aim of this study was to examine in detail the cardiovascular
remodeling responses in real-world, young, novice marathon
runners and explore any differences between men and women.
There were a number of key study findings; first, that running a
first marathon results in concentric biventricular remodeling that
is more modest than previous longitudinal studies of marathon
runners (Arbab-Zadeh et al., 2014; Zilinski et al., 2015). Second,
a modest BP reduction was seen. Third, these changes occurred
without an improvement in peak VO2 and finally, responses were
similar in men and women.
Blood Pressure and Renal Biochemistry
The reductions in peripheral and central BP demonstrated
in this study were accompanied by a reduction in aortic
pulse wave velocity, which is intriguing and suggests that a
reduction in vascular stiffness may play a mechanistic role
in normotensive, young exercising individuals. These findings
have been reported previously in an extended cohort of this
study, including older runners and finding greater regional
distenibility in the descending aorta after marathon running
(Bhuva et al., 2020). Though a 4/2 mmHg BP reduction seems
small, this is highly consistent with the effect of exercise
on BP reported in large meta-analyses, which is comparable
with the effect of antihypertensive medication (Cornelissen
and Smart, 2013; Naci et al., 2018) and also on aortic
pulse wave velocity (Ashor et al., 2014). In terms of clinical
relevance, if sustained, a 2 mmHg systolic BP reduction would
be expected to reduce mortality from stroke by 10% and
from vascular and ischemic heart disease by 7%, even in a
low-risk, normotensive population (Lewington et al., 2002),
underscoring the important role of increased physical activity
in public health policy. It is recognized that age-matched,
premenopausal women have lower BP than men (Maranon and
Reckelhoff, 2013). In sub-group analysis women were noted
to have a greater BP reduction post marathon than men,
however, as we have limited information regarding important
confounding factors such as training volume, intensity, lifestyle,
and menstrual cycle stage, this finding should be interpreted
with caution. Whether a favorable vascular remodeling response
might contribute to the markedly lower incidence of sudden
cardiac arrest during exercise in women (Marijon et al., 2011)
merits further investigation.
Frontiers in Physiology | www.frontiersin.org 7 March 2020 | Volume 11 | Article 232
fphys-11-00232 March 16, 2020 Time: 15:36 # 8
D’Silva et al. Real-World Marathon Cardiovascular Remodeling
FIGURE 3 | Marathon race finishing times by fastest percentile of each cohort comparing study participants with the London Marathon General Race 2016.
A fall in serum creatinine is also an intriguing finding.
Though marathon running has been associated with a substantial
increase in serum creatinine and renal tubular injury on urine
microscopy immediately afterward, this improves after 24 h
(Mansour et al., 2017). Regular running training is associated
with a fall in serum creatinine 2 weeks before a marathon race
(Zilinski et al., 2015) and 2 weeks afterward, despite the acute
rise on race day (Hewing et al., 2015). Future studies examining
this dynamic relationship between exercise and renal function
would be valuable, particularly including assessment of arterial
wall mechanics and endothelial function.
Cardiac Structural Remodeling
We demonstrate a balanced, eccentric remodeling response,
which is comparable between men and women. These changes
are modest in comparison to previous, smaller studies involving
running training in preparation for an endurance event with key
differences in study populations and methodologies summarized
in Table 4.
The intensity of peak training prior to the endurance event
was greatest in the study by Arbab-Zadeh et al. (2014) where
subjects trained for 7–9 h per week in the last 3 months
of a year-long supervised program and demonstrated the
greatest magnitude of cardiac remodeling and cardiorespiratory
fitness response. Zilinski et al. (2015) training a larger
population of older, male runners for 4 h per week achieving
an average distance of 40 km per week, demonstrated
smaller remodeling and cardiorespiratory fitness responses.
Our study provided no supervised training intervention and
observed in real-world novice marathon runners that cardiac
remodeling is even more modest, without cardiorespiratory
fitness improvement. This is consistent with a previously
proposed schema that with increasing intensity and volume of
training, subjects advance through a spectrum of increasing
fitness and cardiac remodeling (Beaudry et al., 2016). The
finding of a fall in ECV, though a recognized remodeling
response in athletes (McDiarmid et al., 2016), is unlikely
to represent a genuine change in myocardial structure as it
was proportional to the rise in blood hematocrit, without
any changes in the constituent myocardial or blood T1
mapping values pre or post contrast. The change in blood
hematocrit is likely to be the result of seasonal variation
and training effect, which has been previously described
(Banfi et al., 2011).
This study found similar proportionate cardiac structural
remodeling responses between men and women, who
were advised to follow a 17-week beginner’s training plan.
A subsequent analysis of the study by Arbab-Zadeh et al.
when comparing seven men to five women, found that despite
exactly the same training, women experienced a blunting of
cardiovascular response with peak VO2, LV mass, and mean wall
thickness plateauing after only 3 months of training, compared to
months 9–12 in men (Howden et al., 2015). The likely reason for
the differences observed in these studies relates to the differences
in exercise volume, intensity, and duration. This suggests that
there may be a dose–response relationship, where a threshold of
exercise stimulus must be reached before differential responses
in men and women are seen, which may be influenced by body
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FIGURE 4 | Weekly time spent undertaking exercise by 38 subjects returning training logs. Blue shaded area represents the 17-Week Beginners Training Plan
period. Boxplots represent the weekly distribution of time spent in exercise, highlighting the median and interquartile ranges. The Virgin Money London Marathon
Beginner 17-Week Training Plan is overlaid to demonstrate the weekly exercise time targets the subjects should have been reaching. Week 17 includes the time
spent running the marathon and achieving an average finishing time.
size, sex hormone profile, and hemodynamic response to exercise
(Zemva and Rogel, 2001).
Cardiorespiratory Fitness
It was unexpected to find no difference in peak VO2 and
only 11% of runners demonstrating a likely cardiorespiratory
training response. The observed fall in ventilatory threshold
post-marathon, despite longer exercise time and higher peak
power achieved may represent overreaching injury, which has
previously been recognized in marathon runners (Kasikcioglu
et al., 2008; Sierra et al., 2016). Based on the findings of
the HERITAGE Family Study, which demonstrated a strong
genetic determination of maximal VO2, we had anticipated
a potential increase of up to 16% in maximal VO2, with
wide variability in training response (Bouchard et al., 1999).
The aforementioned studies of marathon runners showed a
4–18% increase in peak VO2 (Arbab-Zadeh et al., 2014;
Zilinski et al., 2015), where the training was supervised and
exercise doses were greater than in our study. In addition
to volume, intensity of training also affects cardiorespiratory
fitness response, with several studies demonstrating superiority
of high intensity interval training over moderate intensity
continuous training (Wisløff et al., 2007; Milanovic´ et al.,
2015; Williams et al., 2019). Therefore, training administered
by experienced coaches under supervision plays an important
contribution to increasing peak VO2, which real-world novice
marathon runners following beginners training plans generally
do not have. In addition, we did not observe changes
in body fat, weight, or resting heart rate, which can be
surrogate markers of athletic conditioning (Liou et al., 2016;
Viana et al., 2019). Although we found no differences in
cardiovascular remodeling or training volumes between likely
cardiorespiratory responders and likely adverse responders,
owing to the small number of subjects satisfying these
definitions and fewer still recording training logs, there is a
risk of type II statistical error, being unable to reject a false
null hypothesis.
Despite an increase in peak VO2 not being demonstrated in
this study, a small substudy of this work previously reported that
muscle VO2, measured by near-infrared spectroscopy, increased
by 48% after a first marathon run (Jones et al., 2017). Intriguingly,
this suggests that adaptations in skeletal muscle improving
metabolic capacity occur independently of peak VO2 and when
cardiovascular remodeling responses are modest. Future work
exploring muscle arteriolar recruitment, perfusion, and their
relationships with cardiovascular afterload and BP reduction
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TABLE 2 | Cardiac imaging, hemodynamic, cardiorespiratory, and allometric
measurements at baseline and post marathon.
Baseline Post marathon P-value
Echocardiography
iLV EDV (ml/m2) 58.2 ± 12.2 62.5 ± 13.7 <0.01
iLV ESV (ml/m2) 22.4 ± 5.9 26.0 ± 7.0 0.02
LV EF (%) 58.0 ± 4.7 58.5 ± 5.0 0.38
Exercise
echocardiography
5-min exercise LV EF (%) 69.0 ± 3.4 66.7 ± 9.1 0.70
5-min exercise iLV SV
(ml/m2)
81.4 ± 17.4 82.4 ± 19.6 0.20
CMR and hematocrit
iLV EDV (ml/m2) 91.2 ± 14.3 94.3 ± 14.8 <0.01
iLV ESV (ml/m2) 33.3 ± 7.5 34.8 ± 8.2 0.02
LV EF (%) 63.5 ± 5.0 63.2 ± 5.5 0.71
iLV mass (g/m2) 65.2 ± 11.9 68.1 ± 11.4 <0.01
Mean LV wall thickness
(mm)
7.0 ± 0.9 7.1 ± 0.9 0.02
Native T1 (ms) 1011 ± 24 1009 ± 36 0.66
ECV (%) 26.8 ± 2.3 25.7 ± 2.4 <0.01
Hematocrit 0.42 ± 0.03 0.43 ± 0.04 <0.01
Native T2 (ms) 45.3 ± 3.5 45.5 ± 3.1 0.76
iRV EDV (ml/m2) 92.8 ± 14.4 97.1 ± 16.0 <0.01
iRV ESV (ml/m2) 40.5 ± 7.7 42.0 ± 9.1 0.01
RV EF (%) 56.7 ± 4.5 56.9 ± 4.4 0.71
CPET
Peak VO2 (ml/min/kg) 37.1 [32.8, 42.7] 37.5 [33.5, 42.0] 0.14
Percentage predicted peak
VO2 (%)
107.3 ± 16.1 109.6 ± 16.7 0.18
Ventilatory threshold as
percentage of peak
VO2 (%)
61.4 ± 9.6 57.2 ± 8.6 <0.01
Exercise time (s) 578.2 ± 92.3 609.9 ± 101.7 0.01
Peak power (W) 200 [175, 265] 223 [195, 275] <0.01
OUES (ml/min/L/min) 2686 [2327, 3373] 2582 [2228, 3211] 0.31
Peak HR (bt/min) 170.0 [162.0, 178.0] 171.0 [160.0, 187.0] 0.31
Peak HR percentage
predicted (%)
88.67 ± 7.93 87.57 ± 6.26 0.37
Peak RER 1.21 ± 0.09 1.20 ± 0.09 0.67
Blood pressure and
aortic PWV
Systolic BP (mmHg) 120 ± 12 116 ± 12 <0.01
Diastolic BP (mmHg) 74 ± 5 72 ± 6 <0.01
CMR whole aorta PWV
(m/s)
5.1 [4.8, 5.8] 4.9 [4.6, 5.6] 0.02
Allometry and renal
function
Body mass index 23.4 ± 2.9 23.5 ± 2.6 0.42
Body fat (%) 22.7 ± 7.8 22.5 ± 8.6 0.59
Creatinine (µmol/L) 74 ± 14 69 ± 13 <0.01
Data expressed as mean ± SD if normally distributed. If non-normally distributed
data expressed as median [IQR]. BP, blood pressure; CMR, cardiac magnetic
resonance; CPET, cardiopulmonary exercise test; ECV, extracellular volume; EDV,
end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; HR, heart
rate; iLV indexed left ventricular; iRV, indexed right ventricular; LV, left ventricular;
max, maximal; OUES, oxygen uptake efficiency slope; PWV, pulse wave velocity;
RER, respiratory exchange ratio; RV, right ventricular; VO2, oxygen consumption.
would be valuable to understand what influence exercise may
have on these mechanisms.
Myocardial Injury
By evaluating runners 16 ± 4 days after the race, we could
not reproduce evidence of ventricular dysfunction or myocardial
edema found in previous studies (Neilan et al., 2006a; La Gerche
et al., 2012; Gaudreault et al., 2013). These studies conducted
tests immediately after (Neilan et al., 2006a; La Gerche et al.,
2012) or within 2 days of race completion (Gaudreault et al.,
2013). We intended to avoid immediate post-race evaluation
due to the inherent differences in loading conditions, circulating
catecholamines, sympathetic and vasomotor activation affecting
outcomes of interest. If alterations in myocardial edema, strain,
systolic or diastolic function occurred in the study participants,
based on these previous studies, we would expect that they should
normalize by the time of our assessment (Neilan et al., 2006b; La
Gerche et al., 2012; Gaudreault et al., 2013).
As transient cardiac biomarker elevation has been shown to
normalize by 36 h of race completion (Shave et al., 2007, 2010;
Lippi et al., 2011; Scherr et al., 2011) and we found no clinical
reason to suspect persistent elevation, such as myocardial fibrosis,
we did not investigate this in our study.
Future research elucidating the biological mechanisms
responsible for the beneficial effects of regular exercise, such as
the reduction in arterial stiffness, may yield novel therapeutic
strategies, ultimately aiming to harness the anti-atherosclerotic
(Nocon et al., 2008), anti-obesity, anti-diabetic, anti-osteoporotic
(Warburton et al., 2010), anti-cancer (Moore et al., 2016),
antidepressant, and anti-dementia properties of physical activity
(Hamer et al., 2014).
The chief strengths of the study were the careful and
comprehensive phenotyping using state of the art cardiovascular
imaging, balanced gender inclusion, and relatively large
sample size for a longitudinal study of this nature with
multiple tests conducted. The recruitment process, advertising
to all potential subjects through the race organizers and
the inclusion of all subjects regardless of adherence to a
beginner’s training plan allowed for the greatest generalizability,
providing important real-world evidence on the effects of
modest training on young, novice marathon runners and their
cardiovascular health.
Limitations
Although inclusivity of undertrained marathon completers can
be viewed as a strength of the study, it simultaneously represents a
significant weakness as detailed training information was missing
from the majority of subjects, which would have been valuable
in examining undertraining and further associations between
training volume or intensity and cardiovascular remodeling
responses. Similarly, reductions to the final sample size through
loss to follow up also impaired our ability to detect small
changes with accuracy.
Treadmill cardiopulmonary exercise testing would have
been the preferred method to assess cardiorespiratory fitness
changes in marathon runners; however, we used semi-recumbent
tilting cycle ergometers to facilitate dynamic assessment of
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TABLE 3 | Cardiac imaging, hemodynamic, cardiorespiratory, and allometric measurements at baseline and post marathon, separated by gender.
Baseline male
subjects
Post marathon
male subjects
Change P-value Baseline female
subjects
Post marathon
female subjects
Change P-value
iLV EDV (ml/m2) 98.1 ± 14.2 101.0 ± 14.7 2.9 0.02 83.2 ± 9.5 86.4 ± 10.6 3.2 <0.01
iLV ESV (ml/m2) 36.2 ± 8.7 38.2 ± 8.7 2.0 <0.01 30.0 ± 3.7 30.7 ± 5.2 0.7 0.44
LV EF (%) 63.4 ± 5.2 62.3 ± 5.4 -1.0 0.20 63.7 ± 4.8 64.3 ± 5.6 0.6 0.59
iLV Mass (g/m2) 72.9 ± 10.4 76.0 ± 8.7 3.1 <0.01 56.3 ± 5.4 59.0 ± 6.3 2.7 <0.01
Mean LV wall size (mm) 7.6 ± 0.7 7.7 ± 0.6 0.1 0.08 6.3 ± 0.6 6.4 ± 0.5 0.1 0.16
Native T1 (ms) 1001 ± 20.20 992.6 ± 30.46 -8 0.18 1023 ± 22.42 1028 ± 33.26 5 0.51
ECV (%) 25.3 ± 1.8 24.3 ± 1.7 -1.0 <0.01 28.3 ± 1.6 27.1 ± 2.3 -1.3 0.02
iRV EDV (ml/m2) 100.2 ± 13.9 104.4 ± 15.5 4.2 0.02 84.2 ± 9.3 88.5 ± 12.0 4.3 <0.01
iRV ESV (ml/m2) 43.9 ± 7.4 45.9 ± 9.1 2.0 0.05 36.0 ± 5.8 37.6 ± 6.8 1.5 0.11
RV EF (%) 56.2 ± 4.2 56.2 ± 4.5 0 0.98 57.2 ± 4.8 57.7 ± 4.1 0.5 0.63
CPET
Peak VO2 (ml/min/kg) 40.5 ± 6.8 42.6 ± 8.0 2.1 0.11 35.2 ± 4.5 35.3 ± 5.9 0.2 0.81
Percentage predicted Peak VO2 (%) 99.7 ± 15.8 105 ± 18.0 5.3 0.11 115.2 ± 12.4 117.6 ± 15.1 2.4 0.37
Anaerobic threshold as percentage
of Peak VO2 (%)
59.6 ± 9.9 55.9 ± 8.4 -3.7 0.05 63.3 ± 9.1 58.6 ± 8.7 -4.7 0.07
Blood pressure and aortic PWV
Systolic BP (mmHg) 124 ± 12 122 ± 11 -2 0.09 114 ± 10 109 ± 8 -5 <0.01
Diastolic BP (mmHg) 75 ± 5 73 ± 6 -2 0.13 73 ± 5 70 ± 5 -3 0.02
CMR whole aorta PWV (m/s) 5.4 ± 1.1 5.2 ± 0.8 -0.2 0.22 5.3 ± 1.0 4.9 ± 0.7 -0.4 0.08
Allometry and renal function
BMI 24.1 ± 3.1 23.9 ± 2.6 -0.2 0.32 22.5 ± 2.4 23.0 ± 2.6 0.4 0.04
Body fat (%) 17.6 ± 5.6 16.4 ± 5.2 -1.2 0.01 28.4 ± 5.7 29.3 ± 6.2 0.9 0.06
Data expressed as mean ± SD if normally distributed. If non-normally distributed data expressed as median [IQR]. BP, blood pressure; CMR, cardiac magnetic resonance;
CPET, cardiopulmonary exercise test; ECV, extracellular volume; EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; iLV indexed left ventricular;
iRV, indexed right ventricular; LV, left ventricular; max, maximal; METS, metabolic equivalent of task; OUES, oxygen uptake efficiency slope; PWV, pulse wave velocity; RV,
right ventricular; VO2, oxygen consumption.
cardiac function and peripheral blood flow (Jones et al., 2017).
As the post marathon cardiopulmonary exercise test took
place after 7–21 days of detraining, peak VO2 and ventilatory
threshold values may have declined from peak performance
levels by variable amounts. In addition, subjects who did
not achieve the recommended preparatory training may
have suffered a reduction in performance after running the
marathon resulting from an overreaching syndrome (Kasikcioglu
et al., 2008). These limitations may have been addressed
by additional assessments at interim time points during
training, which would have the potential to enhance our
understanding of phasic cardiac remodeling (Arbab-Zadeh
et al., 2014; Weiner et al., 2015) and peak VO2 dynamics
pre and post race.
This study did not include a control group, instead each
subject acted as their own control investigating the association
between training as a transient exposure and cardiovascular
remodeling as an outcome. Therefore, the changes observed
may have resulted from confounding factors, such as seasonal
differences between October 2015 (baseline) and May 2016 (post
marathon), rather than a causal effect of exercise training. BP
is susceptible to seasonal differences (Alpérovitch et al., 2009),
with 35 years olds experiencing a 2/2 mmHg lower BP on a
warm summer day compared to a cold winter day (Brennan
et al., 1982). A proposed mechanistic explanation suggests that
longer daytime length and higher vitamin D levels may be
responsible for a small BP reduction (Witham et al., 2009);
however, exposure to sunlight is a challenging variable to control
for between exercisers and sedentary controls. Though we were
able to record that nine women (28%) were using combined
oral contraception, one woman was using the progesterone-
only pill (3%) and one woman had a levonorgestrel-releasing
intrauterine system (3%) during the study, we did not obtain
information regarding menstrual cycle stage at the time of testing.
Oral contraceptive use can be associated with increases in BP
and stages of the menstrual cycle can affect baroreflex control
of sympathetic activity (Joyner et al., 2016). We were not able
to evaluate these interactions in this study, which may have
confounded the results.
With respect to harm in endurance running, this study was
not designed to address rare but clinically important events such
as sudden cardiac arrest or its causes. The majority of sports-
related sudden cardiac arrests in the general population occur in
men over 35 years of age with occult atherosclerotic coronary
disease (Marijon et al., 2011, 2015), who were not included in
this study. Future studies investigating the causes of sudden
cardiac arrest during mass participation events will require a
national registry with mandatory reporting (Maron et al., 2009)
combined with systematic clinical investigation of victims and
potentially including their families where no cause is found (Behr
et al., 2008; Papadakis et al., 2013, 2018; Basso et al., 2017;
Lahrouchi et al., 2017).
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FIGURE 5 | Summary of principal findings of cardiovascular remodeling following training for a first marathon run, including waterfall plot of cardiorespiratory fitness
response. EDV, end-diastolic volume; LV, left ventricular; RV, right ventricular; VO2, oxygen consumption.
TABLE 4 | Comparative summary of longitudinal cardiac remodeling studies in marathon runners including preparatory training.
Study Year Subjects,
n
Mean
age (y)
Female
(%)
Exercise
exposure
Imaging
modality
Peak exercise
(h/week)
Increase in
peak VO2 (%)
Summary
Arbab-Zadeh
et al. Circulation
2014 12 29 42 Running for
1 year—
supervised
CMR 7–9 17.6 Increased LV mass by 21%, LVEDV by
18%, LV wall thickness by 16%, RV
mass by 30%, and RVEDV by 27%.
Early concentric LV remodeling then
later eccentric remodeling response. RV
remodeling was eccentric throughout
Zilinski et al. Circ
cardiovasc
imaging
2015 45 48 0 Running for
18 weeks—
supervised
Echo 4 3.8 Increased LV mass by 14%, LVEDV by
10%, LV wall thickness by 5%, LV
length by 5%, RVEDA by 6%, and
LAEDV by 11%. Enhanced LV diastolic
function
Present study 68 30 47 Running for
17 weeks—
unsupervised
Echo CMR 2.7–3.9* NS Increased LV mass by 4%, LVEDV by
3%, LV wall thickness by 2%, and
RVEDV by 5%. Modest eccentric
biventricular remodeling. BP reduced
by 4/2 mmHg and aortic PWV by 4%
CMR, cardiac magnetic resonance; Echo; echocardiography; LAEDV, left atrial end-diastolic volume; LV, left ventricular; LVEDV, left ventricular end-diastolic volume; NS,
not significant; RVEDA, right ventricular end-diastolic area; RVEDV, right ventricular end-diastolic volume. *2.7 h/week was the median training time over the 8 weeks prior
to the race, recorded from 32% of the study cohort. 3.9 h/week was the median training time over the final 8 weeks of the recommended beginner’s training plan, which
the study participants were encouraged to follow.
CONCLUSION
Despite ongoing concerns regarding the cardiovascular safety
of marathon running, this study demonstrates a reduction in
BP and vascular stiffness in real-world, young, normotensive
men and women. These benefits come despite more modest
cardiovascular remodeling and cardiorespiratory fitness
responses than previously reported in studies involving
supervised training. We found no evidence of myocardial injury
in first time marathon runners achieving an average finishing
time. In clinical practice, real-world evidence of the effects of
typical marathon training on cardiovascular health provides
important information for the public and medical profession
about an increasingly popular mass participation event.
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